Planet Labs PBC Stock Faces Bearish Charts Despite Record $116M Revenue Beat

Planet Labs PBC stock enters this week at a genuine crossroads. The technical structure remains firmly bearish, but a blowout earnings report just shifted the fundamental backdrop. That tension defines this analysis.

PL — daily chart with candlesticks, EMA20/EMA50 and volume.

Key takeaways

• Planet Labs PBC stock closed at $18.35 on September 3, well below its 20-day, 50-day, and 200-day EMAs.
• The daily RSI14 sits at 29.35, nearing oversold territory, while MACD remains firmly negative at -1.32.
• Q2 FY2027 revenue reached a record $116 million, with FY2027 guidance raised to $430 million–$441 million.
• The daily pivot at $18.76 and S1 support at $17.42 define the immediate battle zone for bulls and bears.
• Elevated ATR14 at $1.11 signals continued wide-range volatility in the sessions ahead.

Daily Trend: Structure Still Favors Sellers

The daily trend structure unequivocally favors sellers, with price buried beneath every major moving average.

PL closed at $18.35 after opening at $19.86 and touching a low of $17.84. Volume exceeded 31 million shares. That heavy, wide-range session confirms the daily regime reading of “bearish.”

Notably, price sits well below all three key moving averages. The 20-day EMA is at $21.39, the 50-day EMA at $24.19, and the 200-day EMA at $25.13. This stacked bearish alignment shows Planet Labs PBC stock is trending lower across every meaningful lookback period. Rallies into these averages have so far met selling.

Momentum, Bands, and Pivots Reinforce the Downtrend

At the same time, momentum indicators back up the bearish picture. RSI14 on the daily reads 29.35, edging toward oversold territory but not yet flashing a reversal signal. MACD sits at -1.32 with a signal line of -1.07 and a histogram of -0.24. This confirms that downside momentum, while stretched, has not yet turned.

Meanwhile, Bollinger Bands add useful context. Price trades near the lower band at $18.32. The mid-band is far above at $22.12 and the upper band at $25.91. That proximity to the lower band typically signals an oversold extreme. It can either precede a bounce or confirm a strong trend continuation lower.

Volatility is elevated too. ATR14 stands at $1.11, a wide range relative to the stock’s price. This reflects how violently PL has been moving in recent sessions. On the pivot framework, the daily pivot point is $18.76, with resistance at $19.69 (R1) and support at $17.42 (S1). Price closing below the pivot keeps sellers in control on this timeframe.

1H Timeframe: Confirms the Bearish Bias, With Early Signs of Fatigue

The hourly chart confirms the daily bearish bias, but momentum is showing early signs of exhaustion at this granularity.

The EMA20 at $19.07, EMA50 at $19.94, and EMA200 at $22.01 are all above the current $18.35 close. This reinforces the same bearish alignment seen on the daily. The regime here is also flagged as bearish.

However, momentum on the 1H is somewhat less extreme. RSI14 reads 34.92, a touch higher than the daily reading. This suggests selling pressure has eased slightly. MACD at -0.5 versus a signal of -0.41 leaves a histogram of just -0.09, notably smaller than the daily histogram. That narrower gap hints downside momentum may be losing steam intraday. Still, the broader trend direction has not changed.

Price is holding just above the 1H pivot point of $18.32, with resistance at $18.58 and support at $18.09. This tight range suggests the market is digesting the prior session’s drop rather than extending it aggressively.

15-Minute View: Consolidation Near Short-Term Balance

The 15-minute chart shows consolidation near short-term equilibrium, with no clear directional bias at the micro level.

On the 15-minute chart, price is essentially sitting on its own EMA20 at $18.35. The EMA50 at $18.82 and EMA200 at $19.99 remain above it. RSI14 at 46.6 is neutral, neither overbought nor oversold. The MACD histogram has flipped slightly positive at 0.06. The MACD line (-0.25) still stays below its signal (-0.31). That is a subtle early sign of stabilization. However, it remains far too small to challenge the dominant downtrend on higher timeframes.

The 15m pivot sits at $18.38, with resistance at $18.52 and support at $18.21. Price is effectively pinned between those two levels. This pattern is consistent with a market waiting for a fresh catalyst before committing to direction.

The Fundamental Wildcard: A Strong Quarter Complicates Planet Labs Stock Outlook

The earnings beat introduces a genuine complication for the bearish technical thesis on Planet Labs PBC stock.

This is where the setup gets genuinely complicated. The daily candle used in this analysis closed on September 3. Planet Labs reported its Q2 FY2027 earnings after that same session’s close. The results were strong. Revenue hit a record $116 million for the quarter. The company reported a $4 billion satellite pipeline and raised FY2027 revenue guidance to $430 million–$441 million. The company also lifted its capital expenditure plans to $100 million–$115 million while accelerating its Owl program.

Citizens reiterated its rating on the stock following that revenue strength. Separate coverage noted the shares were surging in the session after the report, alongside a broader market rally. Major indexes closed more than 1% higher that day as Treasury yields slid. Meanwhile, a Motley Fool comparison piece framed Planet Labs alongside Snowflake as a high-growth, still-unprofitable name. Both companies are now posting more than 30% year-over-year sales growth.

In other words, the technical damage on the daily chart largely predates a fundamental catalyst that appears to have shifted sentiment abruptly. That sequencing matters. The bearish structure described above reflects price action into September 3, not the post-earnings reaction. Traders should weigh that gap carefully.

Bullish Scenario

For bulls, the path forward depends on the earnings beat translating into sustained buying that reclaims lost technical levels.

A push back above the daily pivot at $18.76 would be a first sign of recovery. Clearing the $19.69 R1 level would confirm the post-earnings bounce has legs. Reclaiming the 20-day EMA near $21.39 would signal the broader downtrend is being challenged. The improving 1H MACD histogram and the still-neutral 15m RSI leave room for such a move. This is especially true if guidance raises and pipeline growth keep attracting analyst support, as seen with Citizens’ reiteration.

Bearish Scenario

The bearish case remains straightforward: one earnings pop does not undo a firmly established downtrend.

On the other hand, the bearish case is simple. One earnings pop does not undo a trend defined by three moving averages stacked in bearish sequence. The daily MACD also remains firmly negative. If PL fails to hold above the 1H pivot at $18.32, sellers could regain the initiative quickly. A slip back under the 15m support at $18.21 would add to that pressure. A break of the daily S1 at $17.42 would invalidate any near-term bullish attempt. That could open the door toward testing the lower Bollinger extremes again. With ATR still elevated at $1.11, sharp moves in either direction remain likely.

Closing Thoughts

Planet Labs PBC stock sits at an inflection point where technicals and fundamentals are pulling in opposite directions.

Overall, Planet Labs PBC stock is at an inflection point where technicals and fundamentals are pulling in different directions. The daily trend remains bearish by every measure available here. Yet the scale of the earnings beat and the raised guidance are catalysts that can reset short-term positioning quickly. Therefore, volatility is likely to stay elevated in the sessions ahead. Traders should expect wide intraday ranges as the market reconciles the technical downtrend with the improved fundamental outlook. Given that uncertainty, positioning decisions around Planet Labs stock deserve extra caution. Price action must confirm which force is actually in control.

FAQ

What is the current technical outlook for Planet Labs PBC stock?

The daily chart shows a firmly bearish structure. PL closed at $18.35, well below its 20-day EMA ($21.39), 50-day EMA ($24.19), and 200-day EMA ($25.13). RSI14 at 29.35 nears oversold territory, and MACD remains negative at -1.32.

Did Planet Labs beat earnings expectations?

Yes. Planet Labs reported record quarterly revenue of $116 million for Q2 FY2027. The company also raised its full-year FY2027 revenue guidance to $430 million–$441 million and increased capital expenditure plans to $100 million–$115 million.

What are the key price levels to watch for Planet Labs stock?

The daily pivot at $18.76 serves as the first recovery hurdle. Resistance sits at $19.69 (R1), while support stands at $17.42 (S1). The 1H pivot at $18.32 and 15m support at $18.21 define the near-term floor that bulls must defend.

What did analysts say after the Planet Labs earnings report?

Citizens reiterated its rating on Planet Labs stock following the revenue strength. Broader coverage noted the shares surged in the session after the report, alongside a market rally that saw major indexes close more than 1% higher.

Disclaimer: This article is for informational purposes only and does not constitute financial advice, an investment recommendation, or a solicitation to buy or sell any financial instrument or cryptocurrency. The analysis provided is not indicative of future results. Investing in crypto assets and financial markets carries a high risk of capital loss. Always do your own research (DYOR) and consult a qualified financial advisor before making any decision.

Article produced with the assistance of artificial intelligence and reviewed by the editorial team.